Strikingly, TERT mRNA was only expressed in the tumor with concomitant TERT promoter and BRAFV600E mutations, whereas neither differences in expression of ETS-factors nor the downstream target cyclin D1 were observed (Additional file 3: Figure S1). Here, CCND1 is linked to neoplasm.